MEDICALGORITHMICS SPÓŁKA AKCYJNA financials
MEDICALGORITHMICS SPÓŁKA AKCYJNA
Country: PL Reporting currency: PLN Latest annual report: 2023-12-31
LEI:
259400O65SLJ2CVTSP22 Financial statements
(PLN, as reported — unscaled; 112 line items across 2 annual periods)
| Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Revenue | PLN 43.1M | PLN 62.7M |
| Employee benefits expense | PLN 18.1M | PLN 17.1M |
| Raw materials & consumables used | PLN 7.2M | PLN 12.4M |
| Depreciation & amortisation | PLN 2.4M | PLN 4.0M |
| Operating profit (EBIT) | PLN 433.0K | PLN 17.2M |
| Net finance income / (cost) | -PLN 671.0K | PLN 8.0M |
| Finance costs | PLN 1.5M | PLN 575.0K |
| Profit before tax | -PLN 238.0K | PLN 25.3M |
| Income tax expense | PLN 340.0K | -PLN 216.0K |
| Profit for the year | -PLN 578.0K | -PLN 11.9M |
| — attributable to owners | -PLN 578.0K | -PLN 11.9M |
| — attributable to NCI | PLN 0 | PLN 0 |
| Total comprehensive income | -PLN 2.1M | -PLN 15.9M |
| Per share | ||
| Basic EPS | PLN -0.06 | PLN -2.08 |
| Diluted EPS | PLN -0.06 | PLN -2.08 |
| Free cash flow / share | PLN -0.03 | PLN 1.11 |
| Cash flow statement | ||
| Net cash from operating activities | PLN 182.0K | PLN 6.3M |
| Net cash from investing activities | PLN 2.0M | -PLN 1.8M |
| Purchase of PP&E (capex) | PLN 488.0K | PLN 0 |
| Purchase of intangibles | PLN 10.8M | PLN 12.4M |
| Net cash from financing activities | -PLN 2.8M | PLN 10.0M |
| Proceeds from borrowings | PLN 0 | PLN 0 |
| Repayments of borrowings | PLN 9.0K | PLN 1.5M |
| Lease liability payments | PLN 1.2M | PLN 0 |
| Balance sheet | ||
| Total assets | PLN 121.6M | PLN 122.0M |
| Non-current assets | PLN 78.4M | PLN 65.9M |
| Property, plant & equipment | PLN 2.3M | PLN 2.0M |
| Intangible assets & goodwill | PLN 72.7M | PLN 63.9M |
| Current assets | PLN 43.2M | PLN 56.1M |
| Inventories | PLN 9.3M | PLN 8.8M |
| Trade & other receivables | PLN 8.4M | PLN 21.1M |
| Cash & equivalents | PLN 25.5M | PLN 26.2M |
| Total equity | PLN 92.6M | PLN 94.7M |
| — attributable to owners | PLN 92.6M | PLN 94.7M |
| Non-controlling interests | PLN 9.0K | PLN 9.0K |
| Non-current liabilities | PLN 16.8M | PLN 17.1M |
| Long-term borrowings | PLN 0 | PLN 0 |
| Current liabilities | PLN 12.3M | PLN 10.3M |
| Trade & other payables | PLN 4.4M | PLN 4.5M |
| Deferred tax liabilities | PLN 8.6M | PLN 8.3M |
| Derived metrics | ||
| Free cash flow | -PLN 306.0K | PLN 6.3M |
| Operating margin | 1.0% | 27.4% |
| Net margin | -1.3% | -18.9% |
| Return on equity | -0.6% | -12.5% |
| Cash conversion ratio | -0.31× | -0.53× |
| Capex coverage | 0.37× | — |
| Other reported items | ||
| Accruals Classified As Current | PLN 1.9M | PLN 35.0K |
| Accruals Classified As Noncurrent | PLN 5.6M | PLN 4.2M |
| Adjustments For Amortisation Expense | PLN 1.1M | PLN 2.7M |
| Adjustments For Decrease Increase In Inventories | -PLN 550.0K | -PLN 1.6M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -PLN 4.7M | -PLN 36.3M |
| Adjustments For Depreciation Expense | PLN 1.3M | PLN 1.5M |
| Adjustments For Finance Income | PLN 0 | PLN 0 |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | PLN 861.0K | PLN 1.1M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Loans and Advances | PLN 0 | -PLN 8.3M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | PLN 0 | PLN 63.8M |
| Adjustments For Income Tax Expense | -PLN 1.2M | -PLN 1.8M |
| Adjustments For Increase Decrease In Other Operating Payables | -PLN 1.0K | PLN 5.9M |
| Adjustments For Increase Decrease In Trade and Other Payables | -PLN 174.0K | -PLN 1.4M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | PLN 2.0K | -PLN 13.3M |
| Adjustments For Provisions | PLN 2.5M | PLN 335.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -PLN 1.7M | -PLN 260.0K |
| Basic Earnings Loss Per Share From Continuing Operations | PLN -0.06 | PLN 4.47 |
| Basic Earnings Loss Per Share From Discontinued Operations | PLN 0.00 | PLN -6.55 |
| Cash Flows From Losing Control of Subsidiaries Or Other Businesses Classified As Investing Activities | PLN 13.3M | PLN 20.0M |
| Changes In Equity | -PLN 2.1M | PLN 47.3M |
| Comprehensive Income Attributable To Noncontrolling Interests | PLN 0 | PLN 0 |
| Comprehensive Income Attributable To Owners of Parent | -PLN 2.1M | -PLN 15.9M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | PLN 0 | PLN 9.0K |
| Current Provisions | PLN 2.6M | PLN 641.0K |
| Current Tax Liabilities Current | PLN 174.0K | PLN 125.0K |
| Deferred Tax Assets | PLN 0 | PLN 0 |
| Diluted Earnings Loss Per Share From Continuing Operations | PLN -0.06 | PLN 4.47 |
| Diluted Earnings Loss Per Share From Discontinued Operations | PLN 0.00 | PLN -6.55 |
| Equity and Liabilities | PLN 121.6M | PLN 122.0M |
| Expense By Nature | PLN 42.1M | PLN 46.3M |
| Finance Income | PLN 788.0K | PLN 8.6M |
| Gains Losses On Exchange Differences On Translation Net of Tax | -PLN 1.3M | -PLN 4.0M |
| Income Taxes Paid Refund Classified As Operating Activities | PLN 0 | -PLN 2.1M |
| Increase Decrease In Cash and Cash Equivalents | -PLN 664.0K | PLN 14.5M |
| Increase Decrease Through Acquisition of Subsidiary | PLN 0 | -PLN 178.0K |
| Interest Received Classified As Operating Activities | PLN 53.0K | PLN 0 |
| Issue of Equity | PLN 0 | PLN 63.4M |
| Issued Capital | PLN 995.0K | PLN 995.0K |
| Liabilities | PLN 29.1M | PLN 27.3M |
| Miscellaneous Other Operating Expense | PLN 1.4M | PLN 1.0M |
| Miscellaneous Other Operating Income | PLN 870.0K | PLN 1.9M |
| Noncurrent Financial Assets | PLN 20.0K | PLN 20.0K |
| Noncurrent Provisions | PLN 150.0K | PLN 191.0K |
| Noncurrent Receivables | PLN 3.4M | PLN 0 |
| Other Adjustments For Noncash Items | PLN 1.0M | PLN 11.0K |
| Other Comprehensive Income | -PLN 1.5M | -PLN 4.0M |
| Other Comprehensive Income Attributable To Noncontrolling Interests | PLN 0 | PLN 0 |
| Other Comprehensive Income Attributable To Owners of Parent | -PLN 1.5M | -PLN 4.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -PLN 1.5M | -PLN 4.0M |
| Other Current Financial Liabilities | PLN 3.2M | PLN 5.0M |
| Other Expense By Nature | PLN 1.1M | PLN 657.0K |
| Other Inflows Outflows of Cash Classified As Financing Activities | PLN 0 | -PLN 763.0K |
| Other Inflows Outflows of Cash Classified As Operating Activities | -PLN 117.0K | PLN 46.0K |
| Other Noncurrent Financial Liabilities | PLN 2.5M | PLN 4.2M |
| Other Noncurrent Liabilities | PLN 2.0K | PLN 147.0K |
| Other Reserves | PLN 211.0M | PLN 211.0M |
| Outflows of Cash From Investing Activities | PLN 0 | PLN 9.4M |
| Proceeds From Government Grants Classified As Financing Activities | PLN 1.6M | PLN 0 |
| Proceeds From Issuing Shares | PLN 0 | PLN 13.9M |
| Proceeds From Other Longterm Assets Classified As Investing Activities | PLN 0 | PLN 0 |
| Profit Loss From Continuing Operations | -PLN 578.0K | PLN 25.5M |
| Profit Loss From Discontinued Operations | PLN 0 | -PLN 37.3M |
| Reclassification Adjustments On Exchange Differences On Translation Net of Tax | PLN 355.0K | PLN 0 |
| Reserve of Exchange Differences On Translation | -PLN 2.0M | -PLN 504.0K |
| Retained Earnings | -PLN 117.4M | -PLN 116.8M |
| Services Expense | PLN 13.4M | PLN 12.2M |
Methodology
Every line item above is a fact tagged in MEDICALGORITHMICS SPÓŁKA AKCYJNA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (PLN), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.